Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic-guided dosing of replacement therapy in haemophilia A?

Tine M.H.J. Goedhart, Laura H. Bukkems, the OPTI-CLOT study group and SYMPHONY consortium, Iris van Moort, Colin C. Spence, Michel C. Zwaan, Moniek P.M. de Maat, Ron A.A. Mathôt, Marjon H. Cnossen*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)
42 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic-guided dosing of replacement therapy in haemophilia A?'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences